Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    52,013.96
    +536.41 (+1.04%)
     
  • CMC Crypto 200

    1,334.09
    +21.46 (+1.64%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

STOCKS NEWS EUROPE-AIM index inches lower, BrainJuicer bucks weak trend

Junior-listed AIM shares slip 0.1 percent, lagging the mid-caps and the blue chips, which post respective gains of 0.1 percent and 0.4 percent, but outperforming a 0.3 percent drop on the FTSE Small Cap index .

AIM-listed BrainJuicer, an online market research agency, jumps around 11 percent to an all-time high as it accompanies news of a 17 percent rise in full-year revenue with that of a second special dividend, representing a further 1.5 million pounds ($2.5 million) return of cash.

"BrainJuicer reported a strong set of FY13 results, a touch above our forecasts, but with the surprise announcement of the second 1.5 million pound special dividend in six months," analysts at Canaccord Genuity (Other OTC: CCORF - news) write in a note.

"Given impressive underlying growth and a strong balance sheet, we raise our TP (target price) from 350 pence to 495 pence," they add, repeating their "buy" rating on the stock.

The shares are currently trading at 470.625 pence.

($1 = 0.6057 British Pounds)

Reuters messaging rm://tricia.wright1.thomsonreuters.com@reuters.net